Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Clinical Hypertension|August 31, 2023
Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertensionSungha Park, Sang-Hyun Ihm, In-Jeong Cho, et al.Journal of Human Hypertension|November 26, 2020
The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectivesMiguel Camafort-Babkowski, Akintunde Adeseye, Antonio Coca, et al.Clinical Therapeutics|August 6, 2014
Efficacy and safety of 30-mg fimasartan for the treatment of patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, phase III clinical studyJong-Chan Youn, Sang-Hyun Ihm, Jang-Ho Bae, et al.BMJ Open|October 14, 2017
Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis - coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trialChi-Hoon Kim, Jung-Kyu Han, Han-Mo Yang, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.Clinical Therapeutics|February 11, 2026
Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSang Hyun Lee, Kyungil Park, Ki Hong Lee, et al.International Journal of Cardiology|October 4, 2015
Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trialPyung Chun Oh, Taehoon Ahn, Dong Woon Kim, et al.Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.Plos One|January 30, 2014
SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): a multi-center, retrospective, observational studyByung-Su Yoo, Jaewon Oh, Bum-Kee Hong, et al.Trials|July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trialMin-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.Pageof 8